Synthesis and characterization of 20-hydroxyvitamin D with the A-ring modification.

J Steroid Biochem Mol Biol

Laboratory of Analytical Chemistry, Faculty of Pharmaceutical Sciences at Kagawa Campus, Tokushima Bunri University, Shido, Sanuki, Kagawa, 769-2193, Japan.

Published: March 2019


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Two novel 20-hydroxyvitamin D analogues (4a,b) with the A-ring modification have been synthesized by a convergent manner. An alternative pathway of vitamin D metabolism by cytochrome P450scc CYP11A1 was reported to afford 20-hydroxyvitamin D (3), functions of which remain to be explored. Based on the structure of the 20-hydroxy metabolite, novel analogues (4a,b) with the modifications, including the 1α-hydroxy, 25-hydroxy and 2α-methyl groups, have been designed. The side chain of the requisite CD-ring portions (9a,b) was introduced by Grignard reaction as a key step, and the stereochemistry at the C20 position was confirmed by the X-ray crystal structure analysis of the synthetic intermediate (8b). Preliminary biological characterization using the bovine thymus vitamin D receptor suggested that the introduction of the active motifs into the 20-hydroxyvitamin D scaffold elevated the receptor affinity.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jsbmb.2018.10.019DOI Listing

Publication Analysis

Top Keywords

a-ring modification
8
analogues 4ab
8
synthesis characterization
4
20-hydroxyvitamin
4
characterization 20-hydroxyvitamin
4
20-hydroxyvitamin a-ring
4
modification novel
4
novel 20-hydroxyvitamin
4
20-hydroxyvitamin analogues
4
4ab a-ring
4

Similar Publications

Human aldo-keto reductase 1C3 (AKR1C3) is a steroid modifying enzyme involved in cancer progression. Here, A-ring modified 17α-picolyl and 17()-picolinylidene androstane derivatives are shown to inhibit AKR1C3 activity . None of the androstane derivatives have off-target affinity for the androgen receptor, based on a fluorescence assay in yeast cells.

View Article and Find Full Text PDF

Exploring the mechanism of flavonoid amination and its potential biological implications from an and perspective.

Crit Rev Food Sci Nutr

September 2025

Department of Analytical and Food Chemistry, Faculty of Science, Universidade de Vigo, Nutrition and Bromatology Group, Ourense, Spain.

The discovery of flavonoid amination metabolism has raised research interest in this new biotransformation mechanism. studies have revealed that flavonoids with pyrogallol structures readily react with N-nucleophilic ammonia, where amination occurs at intermediate -OH position, such as the B ring C4'-OH of epigallocatechin gallate and myricetin, A ring C6-OH of baicalein. Flavonoids are also covalently bound with amino acid residue by Schiff base, Michael addition or Strecker degradation, which are further rearranged to generate -NH substituted products.

View Article and Find Full Text PDF

Tetrahydro-β-carboline 1 (MMV008138) controls growth of asexual blood-stage by inhibiting IspD, an enzyme in the MEP pathway for synthesis of a critical metabolite, isopentenyl pyrophosphate (IPP). We have previously investigated the structure activity relationship (SAR) of three of its four rings (B, C, and D). In this report we investigate the SAR of the benzo- ( A-ring) of 1, with the goal of increasing its antimalarial potency and metabolic stability.

View Article and Find Full Text PDF

Parkin, a Ring-InBetweenRING-Rcat E3 ubiquitin ligase, plays a vital role in the clearance of damaged mitochondria (mitophagy) by ubiquitylating a broad spectrum of mitochondrial proteins. Mutations in the PRKN gene alter parkin ubiquitylation activity and are a leading cause of early-onset Parkinsonism, underlining its critical function in maintaining mitochondrial homeostasis. The structures, substrates, and ubiquitylation mechanisms used by parkin in mitophagy are well established.

View Article and Find Full Text PDF

Hypertension is one of the leading causes of mortality related to cardiovascular disease. Since the advent of modern medicine, a multitude of efforts have been made to achieve better blood pressure control. However, despite a wide range of monitoring protocols and medication therapies, only 23% of patients with hypertension achieve blood pressure control.

View Article and Find Full Text PDF